178 related articles for article (PubMed ID: 15890621)
1. Valproic acid glucuronidation is associated with increases in 15-F2t-isoprostane in rats.
Tong V; Teng XW; Karagiozov S; Chang TK; Abbott FS
Free Radic Biol Med; 2005 Jun; 38(11):1471-83. PubMed ID: 15890621
[TBL] [Abstract][Full Text] [Related]
2. Valproic acid I: time course of lipid peroxidation biomarkers, liver toxicity, and valproic acid metabolite levels in rats.
Tong V; Teng XW; Chang TK; Abbott FS
Toxicol Sci; 2005 Aug; 86(2):427-35. PubMed ID: 15858223
[TBL] [Abstract][Full Text] [Related]
3. The effect of valproic acid on hepatic and plasma levels of 15-F2t-isoprostane in rats.
Tong V; Chang TK; Chen J; Abbott FS
Free Radic Biol Med; 2003 Jun; 34(11):1435-46. PubMed ID: 12757854
[TBL] [Abstract][Full Text] [Related]
4. Vascular effects of 15-F2t-isoprostane in spontaneously hypertensive rats.
Marlière S; Cracowski JL; Hakim A; Stanke-Labesque F; Hoffmann P; Bessard G
Can J Physiol Pharmacol; 2005 Jun; 83(6):453-8. PubMed ID: 16049544
[TBL] [Abstract][Full Text] [Related]
5. Oxidative stress in children receiving valproic acid.
Michoulas A; Tong V; Teng XW; Chang TK; Abbott FS; Farrell K
J Pediatr; 2006 Nov; 149(5):692-6. PubMed ID: 17095346
[TBL] [Abstract][Full Text] [Related]
6. Effect of inducers and inhibitors of glucuronidation on the biliary excretion and choleretic action of valproic acid in the rat.
Watkins JB; Klaassen CD
J Pharmacol Exp Ther; 1982 Feb; 220(2):305-10. PubMed ID: 6799642
[TBL] [Abstract][Full Text] [Related]
7. Effect of alpha-fluorination of valproic acid on valproyl-S-acyl-CoA formation in vivo in rats.
Grillo MP; Chiellini G; Tonelli M; Benet LZ
Drug Metab Dispos; 2001 Sep; 29(9):1210-5. PubMed ID: 11502730
[TBL] [Abstract][Full Text] [Related]
8. Quantification of dinor, dihydro metabolites of F2-isoprostanes in urine by liquid chromatography/tandem mass spectrometry.
Davies SS; Zackert W; Luo Y; Cunningham CC; Frisard M; Roberts LJ
Anal Biochem; 2006 Jan; 348(2):185-91. PubMed ID: 16309621
[TBL] [Abstract][Full Text] [Related]
9. Bioactivation of a toxic metabolite of valproic acid, (E)-2-propyl-2,4-pentadienoic acid, via glucuronidation. LC/MS/MS characterization of the GSH-glucuronide diconjugates.
Tang W; Abbott FS
Chem Res Toxicol; 1996 Mar; 9(2):517-26. PubMed ID: 8839057
[TBL] [Abstract][Full Text] [Related]
10. Quantification of the major urinary metabolite of 15-F2t-isoprostane (8-iso-PGF2alpha) by a stable isotope dilution mass spectrometric assay.
Morrow JD; Zackert WE; Yang JP; Kurhts EH; Callewaert D; Dworski R; Kanai K; Taber D; Moore K; Oates JA; Roberts LJ
Anal Biochem; 1999 May; 269(2):326-31. PubMed ID: 10222005
[TBL] [Abstract][Full Text] [Related]
11. Conjugation of glutathione with a toxic metabolite of valproic acid, (E)-2-propyl-2,4-pentadienoic acid, catalyzed by rat hepatic glutathione-S-transferases.
Tang W; Borel AG; Abbott FS
Drug Metab Dispos; 1996 Apr; 24(4):436-46. PubMed ID: 8801059
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the role of in situ generated (E)-2,4-diene-valproic acid in the toxicity of valproic acid and (E)-2-ene-valproic acid in sandwich-cultured rat hepatocytes.
Surendradoss J; Chang TK; Abbott FS
Toxicol Appl Pharmacol; 2012 Nov; 264(3):413-22. PubMed ID: 22940460
[TBL] [Abstract][Full Text] [Related]
13. Chemical and immunochemical comparison of protein adduct formation of four carboxylate drugs in rat liver and plasma.
Bailey MJ; Dickinson RG
Chem Res Toxicol; 1996; 9(3):659-66. PubMed ID: 8728513
[TBL] [Abstract][Full Text] [Related]
14. Aspects of the metabolism of valproic acid.
Granneman GR; Wang SI; Machinist JM; Kesterson JW
Xenobiotica; 1984 May; 14(5):375-87. PubMed ID: 6433565
[TBL] [Abstract][Full Text] [Related]
15. 15-F2t-Isoprostane Concentrations and Oxidant Status in Lactating Dairy Cattle with Acute Coliform Mastitis.
Mavangira V; Mangual MJ; Gandy JC; Sordillo LM
J Vet Intern Med; 2016; 30(1):339-47. PubMed ID: 26566597
[TBL] [Abstract][Full Text] [Related]
16. Panipenum, a carbapenem antibiotic, increases the level of hepatic UDP-glucuronic acid in rats.
Yamamura N; Imura-Miyoshi K; Naganuma H
Drug Metab Dispos; 2000 Dec; 28(12):1484-6. PubMed ID: 11095587
[TBL] [Abstract][Full Text] [Related]
17. An improved GC/MS-based procedure for the quantitation of the isoprostane 15-F2t-IsoP in rat plasma.
Parker CE; Graham LB; Nguyen MN; Gladen BC; Kadiiska MB; Barrett JC; Tomer KB
Mol Biotechnol; 2001 Jun; 18(2):105-18. PubMed ID: 11471453
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of the drug interaction between valproic acid and carbapenem antibiotics in monkeys and rats.
Nakajima Y; Mizobuchi M; Nakamura M; Takagi H; Inagaki H; Kominami G; Koike M; Yamaguchi T
Drug Metab Dispos; 2004 Dec; 32(12):1383-91. PubMed ID: 15345660
[TBL] [Abstract][Full Text] [Related]
19. Panipenem, a carbapenem antibiotic, enhances the glucuronidation of intravenously administered valproic acid in rats.
Yamamura N; Imura K; Naganuma H; Nishimura K
Drug Metab Dispos; 1999 Jun; 27(6):724-30. PubMed ID: 10348803
[TBL] [Abstract][Full Text] [Related]
20. Disposition of valproic acid in the rat: dose-dependent metabolism, distribution, enterohepatic recirculation and choleretic effect.
Dickinson RG; Harland RC; Ilias AM; Rodgers RM; Kaufman SN; Lynn RK; Gerber N
J Pharmacol Exp Ther; 1979 Dec; 211(3):583-95. PubMed ID: 390116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
